Email Print this page Bookmark this page


Thank you for your interest in the LACRISERT® Tip Sheet. The tip sheet provides useful information for your patients regarding insertion and having success with LACRISERT®. You and your office staff can use the tip sheet when discussing LACRISERT® with patients and then provide them a copy to refer to.

Please fill out the information below to customize the tip sheet, click submit, and print out copies to supply to your patients. The tip sheet is two pages, one with insertion instructions and the other with useful tips. You can also write in the patient name and the follow-up appointment information. Thank you for utilizing the LACRISERT® Tip Sheet.

Zip Code
Protecting Your Privacy
In order to provide you with a better Web site experience and better features in the future, we ask you for your e-mail address. If you provide this data, you agree to allow Valeant to link your e-mail address to anonymous (non−personally-identifiable) information that you may have given us previously, or that may have been collected on other Valeant Web sites. We will not sell your e-mail address, and you will not receive e-mail from us that you have not agreed to receive.

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807